Global Assisted Reproductive Technology (ART) Market Size, Share, Growth, Analysis Forecast to 2025

Aug 17, 2018

Assisted Reproductive Technology (ART) Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

Pune, India - August 17, 2018 /MarketersMedia/ —

Assisted Reproductive Technology (ART) Market 2018

Wiseguyreports.Com adds “Assisted Reproductive Technology (ART) Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Assisted Reproductive Technology (ART) Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Assisted Reproductive Technology (ART) Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Assisted Reproductive Technology (ART) market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Assisted Reproductive Technology (ART) market by companies, region, type and end-use industry.

Assisted Reproductive Technology (ART) is the technology used to achieve pregnancy in procedures such as fertility medication, in vitro fertilization and surrogacy. It is reproductive technology used primarily for infertility treatments, and is also known as fertility treatment. It mainly belongs to the field of reproductive endocrinology and infertility, and may also include intracytoplasmic sperm injection (ICSI) and cryopreservation. Some forms of ART are also used with regard to fertile couples for genetic reasons (preimplantation genetic diagnosis). ART is also used for couples who are discordant for certain communicable diseases; for example, HIV to reduce the risk of infection when a pregnancy is desired. 
North America is also expected to witness growth in the coming years. This is due to people awareness towards various fertility options, government support for the in-vitro fertilization and various technological and procedure up gradation. For instance, in August 2015 Ovascience’s treatment named AUGMENT has been reported to have rejuvenated women’s aging egg cells and provided benefits to eggs with poor quality. In February 2015, the scientist of U.S. who invented the three parent IVF procedure requested the Food and Drug Administration (FDA) to grant permission for its clinical trials as age related infertility. 

This report focuses on the global top players, covered 
Irvine Scientific 
Origio a/s 
Vitro Life 
Esco Micro Pte. Ltd. 
IVFtech ApS 
Research Instruments 
Genea Limited 
Smiths Medical 
Thermo Fisher Scientific, Inc. 
Cook Medical

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3322899-global-assisted-reproductive-technology-art-market-size-status-and-forecast-2025

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India

Market segment by Type, the product can be split into 
Fresh Donor 
Fresh Nondonor 
Frozen Donor 
Frozen Nondonor 
Egg/Embryo bank

Market segment by Application, split into 
Women Younger Than Age 35 
Women Older Than Age 35

Key Stakeholders 
Assisted Reproductive Technology (ART) Manufacturers 
Assisted Reproductive Technology (ART) Distributors/Traders/Wholesalers 
Assisted Reproductive Technology (ART) Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/3322899-global-assisted-reproductive-technology-art-market-size-status-and-forecast-2025

Major Key Points in Table of Content:

Global Assisted Reproductive Technology (ART) Market Size, Status and Forecast 2025 
1 Industry Overview of Assisted Reproductive Technology (ART) 
1.1 Assisted Reproductive Technology (ART) Market Overview 
1.1.1 Assisted Reproductive Technology (ART) Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Assisted Reproductive Technology (ART) Market Size and Analysis by Regions (2013-2018) 
1.2.1 United States 
1.2.2 Europe 
1.2.3 China 
1.2.4 Japan 
1.2.5 Southeast Asia 
1.2.6 India 
1.3 Assisted Reproductive Technology (ART) Market by Type 
1.3.1 Fresh Donor 
1.3.2 Fresh Nondonor 
1.3.3 Frozen Donor 
1.3.4 Frozen Nondonor 
1.3.5 Egg/Embryo bank 
1.4 Assisted Reproductive Technology (ART) Market by End Users/Application 
1.4.1 Women Younger Than Age 35 
1.4.2 Women Older Than Age 35

2 Global Assisted Reproductive Technology (ART) Competition Analysis by Players 
2.1 Assisted Reproductive Technology (ART) Market Size (Value) by Players (2013-2018) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles 
3.1 Irvine Scientific 
3.1.1 Company Profile 
3.1.2 Main Business/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Assisted Reproductive Technology (ART) Revenue (Million USD) (2013-2018) 
3.2 Origio a/s 
3.2.1 Company Profile 
3.2.2 Main Business/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Assisted Reproductive Technology (ART) Revenue (Million USD) (2013-2018) 
3.3 Vitro Life 
3.3.1 Company Profile 
3.3.2 Main Business/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Assisted Reproductive Technology (ART) Revenue (Million USD) (2013-2018) 
3.4 Esco Micro Pte. Ltd. 
3.4.1 Company Profile 
3.4.2 Main Business/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Assisted Reproductive Technology (ART) Revenue (Million USD) (2013-2018) 
3.5 IVFtech ApS 
3.5.1 Company Profile 
3.5.2 Main Business/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Assisted Reproductive Technology (ART) Revenue (Million USD) (2013-2018) 
3.6 Research Instruments 
3.6.1 Company Profile 
3.6.2 Main Business/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Assisted Reproductive Technology (ART) Revenue (Million USD) (2013-2018) 
3.7 Genea Limited 
3.7.1 Company Profile 
3.7.2 Main Business/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 Assisted Reproductive Technology (ART) Revenue (Million USD) (2013-2018) 
3.8 Smiths Medical 
3.8.1 Company Profile 
3.8.2 Main Business/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 Assisted Reproductive Technology (ART) Revenue (Million USD) (2013-2018) 
3.9 Thermo Fisher Scientific, Inc. 
3.9.1 Company Profile 
3.9.2 Main Business/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 Assisted Reproductive Technology (ART) Revenue (Million USD) (2013-2018) 
3.10 Cook Medical 
3.10.1 Company Profile 
3.10.2 Main Business/Business Overview 
3.10.3 Products, Services and Solutions 
3.10.4 Assisted Reproductive Technology (ART) Revenue (Million USD) (2013-2018)

Continued….

Contact Info:
Name: NORAH TRENT
Email: [email protected]
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: 841 198 5042

Source URL: https://marketersmedia.com/global-assisted-reproductive-technology-art-market-size-share-growth-analysis-forecast-to-2025/394414

For more information, please visit https://www.wiseguyreports.com/reports/3322899-global-assisted-reproductive-technology-art-market-size-status-and-forecast-2025

Source: MarketersMedia

Release ID: 394414

More News

GISBH: KPWKM prioritises swift reunification of rescued children with families

GISBH: KPWKM prioritises swift reunification of rescued children with families

Oct 15, 2024

KUALA LUMPUR: The immediate return of children rescued during Op Global to their parents and families is a top priority for the Ministry of Women, Family and Community Development (KPWKM). However, its minister, Datuk Seri Nancy Shukri said KPWKM must first ensure that the children’s parents and families can provide adequate and proper care. “For cases where the capability of the parents and families is clearly established, the reunification process can proceed without delay. In more complex situations, intervention programmes will be implemented to ensure the children’s and families’ best interests are safeguarded “The ultimate goal is to reunite these children with their families. However, before this can happen, several factors need to be carefully evaluated. This is not about denying anyone’s rights, but about ensuring the best interests of the children are upheld,” Nancy said during a minister’s briefing session on GISB Holdings Sdn Bhd (GISBH) in the Dewan Rakyat today. As of yesterday, 560 children – 283 boys and 277 girls – had been placed in safe custody after the Social Welfare Department (JKM) obtained a temporary court custody order for two months under Section 25(2)(a) of the Child Act 2001. Meanwhile, Nancy said the Task Force Profiling Team for Op Global found that 94.3 per cent of the 558 profiled children had at least one living biological parent, while 5.7 per cent had no parents or no available information on their parents. Health assessments showed that 51.6 per cent of the children were underweight, falling below the healthy Body Mass Index (BMI), while 46.1 per cent had a normal weight and the remaining children were classified as obese, she added. “Three children have been issued persons with disabilities (PwD) cards, while 27 others display symptoms of disability,” she added. Cognitive assessments were also conducted on 385 children aged seven and above, with 71.9 per cent (277 children) showing no signs of cognitive disorders, she said. “However, 20.26 per cent (78 children) displayed moderate cognitive disorders, while 7.79 per cent (30 children) were found to have severe cognitive impairments,” Nancy said.

Investigations ongoing into incident of empty Johor checkpoint counters with green lights on, blocked pathways

Investigations ongoing into incident of empty Johor checkpoint counters with green lights on, blocked pathways

Oct 15, 2024

PETALING JAYA: A surprise inspection by Johor Public Works, Transport, Infrastructure, and Communications committee chairman, Mohamad Fazli Mohamad Salleh recently found 17 Immigration counters at the Johor checkpoint empty. The inspection was conducted following a video circulating online showing the 17 empty counters at the checkpoint in Sultan Abu Bakar Complex (KSAB), triggering public backlash. He confirmed that the surprise inspection found that the incident actually occurred, Harian Metro reported. The video showed the empty counters, with green lights on however, the pathways were closed off to commuters. ALSO READ: Woman calls out Immigration officer for alleged rude behaviour Fazli then instructed that the green lights to be turned off to indicate that the lane is closed, to ensure no one is confused. “If there is no solid reason given regarding the incident, this can be considered intentional,” he was quoted as saying. On the other hand, Johor Immigration director Datuk Mohd Rusdi Mohd Darus said an internal probe will be conducted on the incident. ALSO READ: Woman expresses gratitude to Johor Immigration officers for returning lost RM1.5k “The internal investigation will determine whether the immigration officer handling the counter neglected their duties or intentionally left the counter without permission. “We will not tolerate this behaviour, and strict disciplinary action will be taken against them if they are found to have neglected their duties. “It is a violation of responsibility, and I take this issue seriously,“ he was quoted as saying.

Malaysia should seize opportunity in global medical devices market - Chang

Malaysia should seize opportunity in global medical devices market - Chang

Oct 15, 2024

KUALA LUMPUR: Malaysian innovators and manufacturers should seize the opportunity to tap into the immense potential of the global medical devices industry, which is projected to reach nearly US$800 billion by 2030, says Science, Technology and Innovation (MOSTI) Minister Chang Lih Kang. Chang noted that Malaysia had many high-quality products and innovators in the medical devices sector, with the government continuously encouraging and supporting industry players in research and development (R&D) and commercialisation efforts. “The market is vast, and we have plenty of room for success. To support R&D, of course, not limited to the medical devices industry, MOSTI offers various funding facilities, grants, matching grants, and equity where we invest in relevant startups,” he said. Chang said this to reporters after officiating the soft launch of INNOMed: Innovation Pitching Powered by PERANTIM, a key event in the International Medical Device Exhibition & Conference (IMDEC) 2024. Also present were Medical Device Authority (MDA) chief executive officer Dr P. Muralitharan, Malaysia Medical Devices Manufacturers Association (PERANTIM) president Johari Abu Kasim, and organising chairman of INNOMed, Dr Hyzan Mohd Yusof. Earlier in his speech, Chang said that under Malaysia’s New Industrial Master Plan (NIMP) 2030, the government aimed to foster synergies between the manufacturing and engineering sectors and the medical devices sector. This includes creating advanced inspection tools, solutions for imaging and endoscopy, implantable devices, and minimally invasive surgical tools. Meanwhile, Muralitharan told Bernama that, according to figures from the Department of Statistics Malaysia (DOSM), Malaysia’s total trade in medical devices, valued at RM25.61 billion from January to July this year, increased by 23.5 per cent compared to the same period in 2023 (RM20.74 billion). He added that the export of medical devices was valued at RM20.15 billion, an increase of 25.7 per cent compared to RM16.02 billion in 2023. In his speech, Dr Hyzan said that medical device innovation presented an opportunity to improve healthcare while boosting the economy, with the industry projected to reach nearly US$2 billion by 2025, making it one of the fastest-growing sectors. “By focusing on innovation, we can create high-skilled jobs, reduce our dependence on imported technologies, and position Malaysia as a global leader. Last year, we spent US$5 billion on medical devices, with 95 per cent being imports. Our goal is to reduce this to 50 per cent within five years,” he said. He also emphasised that close collaboration among universities, innovators, manufacturers, clinicians, and government agencies was key to ensuring that ideas and research transitioned smoothly from laboratories to clinical applications and into the hands of healthcare providers. INNOMed, themed “Unleashing the Power of Medical Technology: Shaping the Future of Healthcare,“ is organised by the MDA and will take place from Dec 10 to 12 at the Kuala Lumpur Convention Centre (KLCC).

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Utara Selatan

Bringing you from Utara to Selatan, we publish travel guides to make sure you will discover new places to visit in Malaysia and try all the local delicacies.

Newsletter